Aethlon Medical Inc financial data

Symbol
AEMD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
11555 Sorrento Valley Road, Suite 203, San Diego, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
BISHOP EQUITIES INC (to 3/13/2000)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 444 % -47.9%
Debt-to-equity 32.5 % +80.3%
Return On Equity -71.7 % -46.6%
Return On Assets -107 % -66.4%
Operating Margin -6.92K % -538%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.9M shares -43.9%
Common Stock, Shares, Outstanding 13.9M shares -43.9%
Entity Public Float 5.5M USD -58.3%
Common Stock, Value, Issued 13.9K USD -43.9%
Weighted Average Number of Shares Outstanding, Basic 7.46M shares +207%
Weighted Average Number of Shares Outstanding, Diluted 7.46M shares +207%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 162K USD -79.5%
Revenue from Contract with Customer, Excluding Assessed Tax 574K USD +95.2%
Research and Development Expense 2.26M USD -12.1%
General and Administrative Expense 3.35M USD -29.6%
Operating Income (Loss) -11.8M USD +4.45%
Net Income (Loss) Attributable to Parent -11.5M USD +7.33%
Earnings Per Share, Basic -3.85 USD/shares +45.2%
Earnings Per Share, Diluted -3.85 USD/shares +45.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.07M USD -29.7%
Cash, Cash Equivalents, and Short-term Investments 250K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 9.55M USD -28.2%
Property, Plant and Equipment, Net 929K USD -27.6%
Operating Lease, Right-of-Use Asset 814K USD -25.1%
Assets 11.4M USD -27.8%
Accounts Payable, Current 1.07M USD +26.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.13M USD +16.9%
Operating Lease, Liability, Noncurrent 574K USD -34%
Liabilities 2.7M USD +0.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.77K USD -8.94%
Retained Earnings (Accumulated Deficit) -157M USD -7.89%
Stockholders' Equity Attributable to Parent 8.71M USD -33.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.77M USD -61.7%
Liabilities and Equity 11.4M USD -27.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD +29.6%
Net Cash Provided by (Used in) Financing Activities 5.38M USD +399%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 13.9M shares -43.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.16M USD -29.5%
Deferred Tax Assets, Valuation Allowance 33.3M USD +10.8%
Deferred Tax Assets, Gross 33.3M USD +10.8%
Operating Lease, Liability 870K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1M USD -23.9%
Property, Plant and Equipment, Gross 1.11M USD +12.4%
Operating Lease, Liability, Current 296K USD +7.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 333K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 324K USD +2.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 60.3K USD -43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 343K USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 26.9M USD +11.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 343K USD
Additional Paid in Capital 166M USD +4.48%
Depreciation, Depletion and Amortization 86.1K USD -4.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD